RIPK2 and inflammatory bowel disease: The fact that both XLP2 and very early-onset (VEO)-IBD XIAP variants confer increased sensitivity to cell death [180] suggests the possibility of a combined role for perturbed NOD2-RIPK2 signalling and RIPK1-mediated cell death in IBD pathogenesis.